Faron Pharmaceuticals Oy (LON:FARN) Stock Crosses Below 200 Day Moving Average – Time to Sell?

Shares of Faron Pharmaceuticals Oy (LON:FARN) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 186.42 ($2.35) and traded as low as GBX 165 ($2.08). Faron Pharmaceuticals Oy shares last traded at GBX 165 ($2.08), with a volume of 2,665 shares changing hands.

Faron Pharmaceuticals Oy Stock Performance

The company has a current ratio of 1.45, a quick ratio of 1.09 and a debt-to-equity ratio of 922.55. The company’s fifty day moving average is GBX 182.17 and its 200 day moving average is GBX 186.42. The company has a market cap of £221.52 million, a P/E ratio of -4.41 and a beta of 0.36.

About Faron Pharmaceuticals Oy

Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.